Effects of the theory of planned behavior and nudge strategy-based intervention on the adherence to anticoagulation treatment in patients with non-valvular atrial fibrillation

被引:6
|
作者
Ding, Yaoyao [1 ]
Jiang, Hui [2 ]
Liu, Jingzhe [1 ]
Chen, Dexin [1 ]
Yang, Fuguo [1 ]
机构
[1] Qingdao Univ, Sch Nursing, Qingdao 266071, Shandong, Peoples R China
[2] Univ Hlth & Rehabil Sci, Qingdao Hosp, Qingdao Municipal Hosp, Emergency Dept, Qingdao 266000, Shandong, Peoples R China
关键词
Non -valvular atrial fibrillation; Anticoagulation; The theory of planned behavior; Nudge; MEDICATION ADHERENCE; RISK;
D O I
10.1016/j.gerinurse.2023.01.023
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Non-valvular atrial fibrillation is associated with the incidence of thromboembolism. Current guidelines recommend preferential use of novel oral anticoagulants (NOAC) in patients with nonvalvular atrial fibrillation. Oral anticoagulation medication adherence rate was relatively low among discharged patients with non-valvular atrial fibrillation.Aim: To investigate the effects of the anticoagulation programs based on the theory of planned behavior and nudge strategy among patients with non-valvular atrial fibrillation.Methods: 130 patients with non-valvular atrial fibrillation were randomized to the intervention group or con-trol group, 72 patients in the intervention group, and 58 patients in the control group with a 6-month follow-up. Medication adherence, intention, attitude, perceived behavioral control and subjective norm and quality of life were assessed.Results: There were significantly differences in the intention, attitude and subjective norm between the two groups at one month, three months and six months follow-up (P <0.01). There were significantly differences in the perceived behavioral control between the two groups at three months and six months follow-up (P <0.01). The medication adherence scale score was higher in the intervention group than in the control group at three months and six months follow-up. However, there were no differences in quality of life between the two groups at one month, three months and six months follow-up.Conclusions: The program based on the theory of planned behavior and nudge strategy can improve medica-tion adherence in patients with non-valvular atrial fibrillation.(c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [1] Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
    Song, Ting
    Xin, Xiao
    Cui, Peirong
    Zong, Mingcan
    Li, Xianhua
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 493 - 500
  • [2] Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation
    Nozawa, T
    Inoue, H
    Iwasa, A
    Okumura, K
    Lee, JD
    Shimizu, A
    Hayano, M
    Yano, K
    CIRCULATION JOURNAL, 2004, 68 (01) : 29 - 34
  • [3] Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study
    Huang, Hong
    Hu, Nai-Qing
    Yang, Jun-Yun
    Xiang, Yu-Luan
    Zhu, Yuan -Zhao
    Du, Qian -Ru
    Yin, Xue-Yan
    Lv, Jin -lin
    Li, Li -Hua
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3491 - 3501
  • [4] Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
    Dhamane, Amol D.
    Hernandez, Inmaculada
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Yuce, Huseyin
    Keshishian, Allison
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 333 - 343
  • [5] Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
    Amol D Dhamane
    Inmaculada Hernandez
    Manuela Di Fusco
    Cynthia Gutierrez
    Mauricio Ferri
    Cristina Russ
    Wan-Lun Tsai
    Birol Emir
    Huseyin Yuce
    Allison Keshishian
    American Journal of Cardiovascular Drugs, 2022, 22 : 333 - 343
  • [6] Persistence to Oral Anticoagulation Treatment in Non-valvular Atrial Fibrillation Patients in the United States
    Dhamane, Amol
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Keshishian, Allison
    CIRCULATION, 2020, 142
  • [7] Evaluation of the Level of Anticoagulation Control in Patients with Non-Valvular Atrial Fibrillation
    Zang, Bill
    Setakis, Efrosini
    van Staa, Tjeerd P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S113 - S114
  • [8] Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
    Yasaka, Masahiro
    JOURNAL OF ARRHYTHMIA, 2012, 28 (06) : 324 - 329
  • [9] Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
    Pugh, Andrew
    Campbell, Charlotte
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation
    Burnett, Allison
    Tiongson, Jay
    Downey, Ross
    Mahan, Charles E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1119 - 1133